Slaughter and May advises the International Finance Facility For Immunisation Company on its issuance of Fixed Rate Notes due 2023

Slaughter and May is advising the International Finance Facility For Immunisation Company (“IFFIm”) on its issuance of U.S.$500,000,000 0.375 per cent. (payable bi-annually) Fixed Rate Notes due 2023 (the “Notes”).  The Notes will be issued under the Debt Issuance Programme established by IFFIm in 2006.

IFFIm will distribute the proceeds of the Notes to Gavi, the Vaccine Alliance (“Gavi”), to provide Gavi with flexible funding for its core immunisation programmes and efforts to develop and distribute eventual COVID-19 vaccines to countries around the world, particularly the poorest.

The Notes will be issued on 6 November 2020 and will be admitted to the official list of the Luxembourg Stock Exchange and to trading on the regulated market of the Luxembourg Stock Exchange.

Citigroup Global Markets Limited, Crédit Agricole Corporate and Investment Bank and The Toronto-Dominion Bank are acting as joint lead managers in connection with the issuance.

Financing
Matthew Tobin Partner
James Szauer Associate